Identification of causal DNA variants that influence gene expression in trans

Active Grant Awarded Last action

Award ID
F31HG015201
Recipient
Awarding agency
Obligated
$50,114

Award facts

Assistance listing
93.172 Human Genome Research
Completion date 8% complete
Place of performance
Minneapolis, MN 55455, USA

Award details come from USAspending.gov.

Description

Abstract
Genetic variation underlies much of the phenotypic variation in important traits, including morphological and physiological phenotypes as well as risk for common diseases, among individuals. Population-scale genome- wide association studies (GWAS) have identified thousands of genetic loci containing variants associated with a variety of complex traits and diseases, but knowledge of variant associations alone does not inform how variants influence these traits. Complementing GWAS is expression quantitative trait loci (EQTL) mapping, which accounts for the transcriptomic effects of DNA variants. This may explain the mechanisms through which trait-associated variants affect phenotype. Given the importance of such information, IT is critical to understand variant effects on gene expression. Most of the variation in gene expression is attributed to trans-acting eqtls, which are difficult to detect due to their smaller effect sizes relative to CIS-eqtls and the need to overcome multiple testing burden in genome-wide scans. Due to these barriers with studying trans-acting variation in humans, we do not know the answers to critical questions about the molecular basis of trans-acting regulatory variation. To address this, the yeast saccharomyces cerevisiae is an ideal model to study trans-acting regulation on phenotypic variation. Previous research in the albert lab applied the power of yeast as a generalizable model for human genetics has shown that most trans-eqtls cluster in hotspots across the genome. These hotspots have an outsized, genome-wide effect on transcript abundance, yet most of the causal variants for these loci are unknown. In two complementary aims, I will (aim 1) dissect and deeply profile a carefully selected set of candidate variants that may affect gene expression in trans in a range of environments, and (aim 2) identify and study trans-acting causal variants at genome-wide scale. Genome engineering, RNA-SEQ, and bioinformatic analyses will be employed. The central hypothesis is that DNA variants that cause trans-EQTL hotspots affect gene expression and cellular growth by altering proteins involved in different biochemical pathways. This proposal leverages yeast trans-EQTL hotspots as an ideal, tractable model with broad relevance for eukaryotic life. Collectively, the impact of the proposed work will be to broaden understanding of the effects of natural genomic variation on phenotype. In addition to the research proposal, the other components of the fellowship application include a comprehensive and rigorous set of research and clinical training plans that will support the successful completion of my MD and PHD degrees and will foster my development into a physician scientist who works to pinpoint causal genes and variants that underlie different conditions and explore the mechanisms through which they affect human health.

Transactions

Action Obligated Date
Amendment $0
Amendment $50,114
Original award $0

Quick answers

Who received award F31HG015201?

F31HG015201 was awarded to Regents Of The University Of Minnesota by National Human Genome Research Institute (National Institutes of Health) on September 23, 2026.

How much is award F31HG015201 worth?

$50,114 has been obligated on F31HG015201.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award